Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis. | J Clin Med | 2023 | 36983094 | PubTator, text mining | PubMed |
| Molecular Profiling of Inflammatory Processes in a Mouse Model of IC/BPS: From the Complete Transcriptome to Major Sex-Related Histological Features of the Urinary Bladder. | Int J Mol Sci | 2023 | 36982831 | PubTator, text mining | PubMed |
| Genetic/Protein Association of Atopic Dermatitis and Tooth Agenesis. | Int J Mol Sci | 2023 | 36982827 | PubTator, text mining | PubMed |
| Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment. | Int J Mol Sci | 2023 | 36982789 | PubTator, text mining | PubMed |
| The Role of IL-13 and IL-4 in Adipose Tissue Fibrosis. | Int J Mol Sci | 2023 | 36982747 | PubTator, text mining | PubMed |
| MicroRNA-155 and Disease-Related Immunohistochemical Parameters in Cutaneous Melanoma. | Diagnostics (Basel) | 2023 | 36980512 | PubTator, text mining | PubMed |
| Identification through machine learning of potential immune- related gene biomarkers associated with immune cell infiltration in myocardial infarction. | BMC Cardiovasc Disord | 2023 | 36978012 | PubTator, text mining | PubMed |
| Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells. | Cancer Res Commun | 2023 | 36968221 | PubTator, text mining | PubMed |
| Pathogenesis of allergic diseases and implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 36964157 | PubTator, text mining | PubMed |
| Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review. | Signal Transduct Target Ther | 2023 | 36964133 | PubTator, text mining | PubMed |
| Mechanistic PK/PD modeling to address early-stage biotherapeutic dosing feasibility questions. | MAbs | 2023 | 36951503 | PubTator, text mining | PubMed |
| Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population. | ERJ Open Res | 2023 | 36949964 | PubTator, text mining | PubMed |
| Insights into receptor structure and dynamics at the surface of living cells. | Nat Commun | 2023 | 36949079 | PubTator, text mining | PubMed |
| Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations. | J Allergy Clin Immunol Pract | 2023 | 36948491 | PubTator, text mining | PubMed |
| The application of Interleukin-2 family cytokines in tumor immunotherapy research. | Front Immunol | 2023 | 36936961 | PubTator, text mining | PubMed |
| The translational revolution in atopic dermatitis: the paradigm shift from pathogenesis to treatment. | Cell Mol Immunol | 2023 | 36928371 | PubTator, text mining | PubMed |
| CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression. | Cancers (Basel) | 2023 | 36900205 | PubTator, text mining | PubMed |
| Racing CARs to veterinary immuno-oncology. | Front Vet Sci | 2023 | 36876006 | PubTator, text mining | PubMed |
| A comparative study of the arazyme-based fusion proteins with various ligands for more effective targeting cancer therapy: an in-silico analysis. | Res Pharm Sci | 2023 | 36873271 | PubTator, text mining | PubMed |
| Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease. | Transl Res | 2023 | 36863609 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=14